Shopping Cart
- Remove All
- Your shopping cart is currently empty
PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN). |
In vitro | PW507 binds to the orthosteric site of the human S1R crystal structure and engages in strong interactions with the receptor. |
In vivo | PW507 (20 mg/kg; intraperitoneal injection; twice daily; for 14 days) demonstrated significant therapeutic efficacy in alleviating mechanical allodynia. |
Molecular Weight | 334.89 |
Formula | C18H27ClN4 |
Cas No. | 2573850-59-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.